Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-25 @ 11:38 PM
NCT ID:
NCT02322593
Group ID:
EG000
Title:
TAS-118/Oxaliplatin
Description:
TAS-118 plus Oxaliplatin
L-OHP was administered intravenously at dose of 85 mg/m2 on day 1, and TAS-118 were administered 30-60 mg orally twice daily for 7 days (day 1 through day 7), repeated every 2 weeks. Treatment was continued during the study period unless any of Study Treatment Discontinuation Criteria was met.
Deaths Number Affected:
22
Deaths Number At Risk:
None
Serious Number Affected:
155
Serious Number At Risk:
352
Other Number Affected:
344
Other Number At Risk:
352
Study:
NCT02322593
Results Section:
NCT02322593
Adverse Events Module:
NCT02322593